These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24744135)

  • 21. Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
    Khessib T; Jha P; Davidzon GA; Iagaru A; Shah J
    Semin Nucl Med; 2024 Mar; 54(2):270-292. PubMed ID: 38342655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography-computed tomography imaging for malignancies in women.
    Viswanathan C; Bhosale PR; Shah SN; Vikram R
    Radiol Clin North Am; 2013 Nov; 51(6):1111-25. PubMed ID: 24210447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET and PET/CT in pediatric oncology.
    Jadvar H; Connolly LP; Fahey FH; Shulkin BL
    Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies.
    Lakhman Y; Nougaret S; Miccò M; Scelzo C; Vargas HA; Sosa RE; Sutton EJ; Chi DS; Hricak H; Sala E
    Radiographics; 2015; 35(4):1295-313. PubMed ID: 26172364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.
    Samim M; El-Haddad GE; Molenaar IQ; Prevoo W; van den Bosch MA; Alavi A; Lam MG
    PET Clin; 2014 Oct; 9(4):469-95, vi. PubMed ID: 26050948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience.
    Cistaro A; Niccoli Asabella A; Coppolino P; Quartuccio N; Altini C; Cucinotta M; Alongi P; Balma M; Sanfilippo S; Buschiazzo A; Piccardo A; Fanelli M; Sambuceti G; Bomanji J; Baldari S; Bisi G; Fanti S; Rubini G
    Hell J Nucl Med; 2015; 18(2):97-102. PubMed ID: 26187207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET Imaging for Gynecologic Malignancies.
    Friedman SN; Itani M; Dehdashti F
    Radiol Clin North Am; 2021 Sep; 59(5):813-833. PubMed ID: 34392921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls.
    De Gaetano AM; Calcagni ML; Rufini V; Valentini AL; Gui B; Giordano A; Bonomo L
    Abdom Imaging; 2009 Nov; 34(6):696-711. PubMed ID: 18791682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
    Kitajima K; Doi H; Kuribayashi K
    Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Established, emerging and future roles of PET/CT in the management of colorectal cancer.
    Herbertson RA; Scarsbrook AF; Lee ST; Tebbutt N; Scott AM
    Clin Radiol; 2009 Mar; 64(3):225-37. PubMed ID: 19185652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-FDG PET in oncology.
    Núñez Miller R; Pozo MA
    Clin Transl Oncol; 2011 Nov; 13(11):780-6. PubMed ID: 22082641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma.
    Tirumani SH; LaCasce AS; Jacene HA
    PET Clin; 2015 Apr; 10(2):207-25. PubMed ID: 25829087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Present and future roles of FDG-PET/CT imaging in the management of lung cancer.
    Kitajima K; Doi H; Kanda T; Yamane T; Tsujikawa T; Kaida H; Tamaki Y; Kuribayashi K
    Jpn J Radiol; 2016 Jun; 34(6):387-99. PubMed ID: 27121156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics.
    Chen Z; Li X; Li F; Ouyang Q; Yu T
    Eur J Radiol; 2010 Sep; 75(3):329-35. PubMed ID: 20576385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET/CT in primary musculoskeletal tumours: a step forward.
    Lakkaraju A; Patel CN; Bradley KM; Scarsbrook AF
    Eur Radiol; 2010 Dec; 20(12):2959-72. PubMed ID: 20577880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular imaging in the management of gynecologic malignancies.
    Lai CH; Lin G; Yen TC; Liu FY
    Gynecol Oncol; 2014 Oct; 135(1):156-62. PubMed ID: 25065896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDG in Urologic Malignancies.
    Høilund-Carlsen PF; Poulsen MH; Petersen H; Hess S; Lund L
    PET Clin; 2014 Oct; 9(4):457-68, vi. PubMed ID: 26050947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET/MRI in Gynecologic Malignancy.
    Larson M; Lovrec P; Sadowski EA; Pirasteh A
    Radiol Clin North Am; 2023 Jul; 61(4):713-723. PubMed ID: 37169433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Positron emission tomography (PET) in malignant ovarian tumors].
    Fularz M; Adamiak P; Czepczyński R; Jarzabek-Bielecka G; Kedzia W; Ruchała M
    Ginekol Pol; 2013 Aug; 84(8):720-5. PubMed ID: 24191507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodal imaging and detection approach to 18F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience.
    Povoski SP; Hall NC; Murrey DA; Chow AZ; Gaglani JR; Bahnson EE; Mojzisik CM; Kuhrt MP; Hitchcock CL; Knopp MV; Martin EW
    World J Surg Oncol; 2011 Nov; 9():152. PubMed ID: 22112047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.